Don’t miss the latest developments in business and finance.

Dr Reddy's Laboratories launches Lamotrigine Orally Disintegrating Tablets

Image
Capital Market
Last Updated : Oct 10 2016 | 6:01 PM IST

In United States market

Dr Reddy's Laboratories announced that it has launched Lamotrigine Orally Disintegrating Tablets in 25 mg, 50 mg, 100 mg and 200 mg, a therapeutic equivalent of generic version of Lamictal ODT (lamotrigine) Orally Disintegrating Tablets in the United States market approved by the USFDA.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Oct 10 2016 | 5:25 PM IST

Next Story